| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nerve growth factor binding | 5.67e-05 | 8 | 29 | 2 | GO:0048406 | |
| GeneOntologyMolecularFunction | neurotrophin binding | 1.33e-04 | 12 | 29 | 2 | GO:0043121 | |
| GeneOntologyBiologicalProcess | nerve growth factor production | 5.33e-06 | 3 | 28 | 2 | GO:0032902 | |
| GeneOntologyBiologicalProcess | neurotrophin production | 2.66e-05 | 6 | 28 | 2 | GO:0032898 | |
| GeneOntologyBiologicalProcess | brain development | 1.17e-04 | 859 | 28 | 7 | GO:0007420 | |
| GeneOntologyBiologicalProcess | central nervous system development | 1.37e-04 | 1197 | 28 | 8 | GO:0007417 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus | 1.42e-04 | 75 | 28 | 3 | GO:0050982 | |
| GeneOntologyBiologicalProcess | head development | 1.77e-04 | 919 | 28 | 7 | GO:0060322 | |
| Domain | Peptidase_S8_Asp-AS | 3.48e-05 | 6 | 29 | 2 | IPR023827 | |
| Domain | PrprotnconvertsP | 4.87e-05 | 7 | 29 | 2 | IPR002884 | |
| Domain | P_proprotein | 4.87e-05 | 7 | 29 | 2 | PF01483 | |
| Domain | S8_pro-domain | 4.87e-05 | 7 | 29 | 2 | IPR032815 | |
| Domain | - | 4.87e-05 | 7 | 29 | 2 | 3.30.70.850 | |
| Domain | S8_pro-domain | 4.87e-05 | 7 | 29 | 2 | PF16470 | |
| Domain | Peptidase_S8_His-AS | 8.32e-05 | 9 | 29 | 2 | IPR022398 | |
| Domain | Peptidase_S8_Ser-AS | 8.32e-05 | 9 | 29 | 2 | IPR023828 | |
| Domain | Peptidase_S8_subtilisin-rel | 1.04e-04 | 10 | 29 | 2 | IPR015500 | |
| Domain | SUBTILASE_ASP | 1.04e-04 | 10 | 29 | 2 | PS00136 | |
| Domain | SUBTILASE_HIS | 1.04e-04 | 10 | 29 | 2 | PS00137 | |
| Domain | SUBTILASE_SER | 1.04e-04 | 10 | 29 | 2 | PS00138 | |
| Domain | Peptidase_S8 | 1.27e-04 | 11 | 29 | 2 | PF00082 | |
| Domain | - | 1.27e-04 | 11 | 29 | 2 | 3.40.50.200 | |
| Domain | Peptidase_S8/S53_dom | 1.27e-04 | 11 | 29 | 2 | IPR000209 | |
| Domain | Propept_inh | 3.12e-04 | 17 | 29 | 2 | IPR009020 | |
| Domain | Furin_repeat | 3.51e-04 | 18 | 29 | 2 | IPR006212 | |
| Domain | FU | 3.51e-04 | 18 | 29 | 2 | SM00261 | |
| Domain | GPS | 1.27e-03 | 34 | 29 | 2 | SM00303 | |
| Domain | GPS | 1.34e-03 | 35 | 29 | 2 | PF01825 | |
| Domain | GPS | 1.42e-03 | 36 | 29 | 2 | PS50221 | |
| Domain | GPS | 1.50e-03 | 37 | 29 | 2 | IPR000203 | |
| Domain | Growth_fac_rcpt_ | 1.78e-03 | 156 | 29 | 3 | IPR009030 | |
| Domain | LDLRA_1 | 2.51e-03 | 48 | 29 | 2 | PS01209 | |
| Domain | LDLRA_2 | 2.62e-03 | 49 | 29 | 2 | PS50068 | |
| Domain | DH_1 | 4.29e-03 | 63 | 29 | 2 | PS00741 | |
| Domain | ConA-like_dom | 4.64e-03 | 219 | 29 | 3 | IPR013320 | |
| Domain | RhoGEF | 4.98e-03 | 68 | 29 | 2 | SM00325 | |
| Domain | DH_2 | 5.27e-03 | 70 | 29 | 2 | PS50010 | |
| Domain | RhoGEF | 5.27e-03 | 70 | 29 | 2 | PF00621 | |
| Domain | DH-domain | 5.41e-03 | 71 | 29 | 2 | IPR000219 | |
| Domain | - | 5.41e-03 | 71 | 29 | 2 | 1.20.900.10 | |
| Domain | - | 5.71e-03 | 73 | 29 | 2 | 2.60.120.260 | |
| Domain | Ig_2 | 5.71e-03 | 73 | 29 | 2 | PF13895 | |
| Domain | Galactose-bd-like | 9.31e-03 | 94 | 29 | 2 | IPR008979 | |
| Domain | - | 9.51e-03 | 95 | 29 | 2 | 2.60.120.200 | |
| Pathway | REACTOME_ASSEMBLY_OF_ACTIVE_LPL_AND_LIPC_LIPASE_COMPLEXES | 1.27e-04 | 11 | 22 | 2 | MM15559 | |
| Pathway | REACTOME_ASSEMBLY_OF_ACTIVE_LPL_AND_LIPC_LIPASE_COMPLEXES | 3.91e-04 | 19 | 22 | 2 | M27839 | |
| Pathway | REACTOME_ATTACHMENT_AND_ENTRY | 3.91e-04 | 19 | 22 | 2 | M41729 | |
| Pathway | REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_RSV_ATTACHMENT_AND_ENTRY | 5.77e-04 | 23 | 22 | 2 | M48234 | |
| Pathway | REACTOME_SIGNALING_BY_NODAL | 5.77e-04 | 23 | 22 | 2 | M511 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_REMODELING | 6.82e-04 | 25 | 22 | 2 | MM15562 | |
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 1741956 | ||
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 17909005 | ||
| Pubmed | Enhanced UV-induced skin carcinogenesis in transgenic mice overexpressing proprotein convertases. | 6.71e-07 | 2 | 29 | 2 | 23441131 | |
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 10050053 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 8670066 | ||
| Pubmed | 4.02e-06 | 4 | 29 | 2 | 12787574 | ||
| Pubmed | CDMP1/GDF5 has specific processing requirements that restrict its action to joint surfaces. | 4.02e-06 | 4 | 29 | 2 | 16829522 | |
| Pubmed | Retroviral envelope glycoprotein processing: structural investigation of the cleavage site. | 4.02e-06 | 4 | 29 | 2 | 9521771 | |
| Pubmed | Cellular processing of the nerve growth factor precursor by the mammalian pro-protein convertases. | 4.02e-06 | 4 | 29 | 2 | 8615794 | |
| Pubmed | The proprotein convertases furin and PACE4 play a significant role in tumor progression. | 4.02e-06 | 4 | 29 | 2 | 10900462 | |
| Pubmed | 4.02e-06 | 4 | 29 | 2 | 26283733 | ||
| Pubmed | Processing of prothyrotropin-releasing hormone by the family of prohormone convertases. | 6.70e-06 | 5 | 29 | 2 | 9242664 | |
| Pubmed | Cripto recruits Furin and PACE4 and controls Nodal trafficking during proteolytic maturation. | 6.70e-06 | 5 | 29 | 2 | 18772886 | |
| Pubmed | 6.70e-06 | 5 | 29 | 2 | 1429684 | ||
| Pubmed | 6.70e-06 | 5 | 29 | 2 | 11380615 | ||
| Pubmed | 6.70e-06 | 5 | 29 | 2 | 18664504 | ||
| Pubmed | 1.00e-05 | 6 | 29 | 2 | 9291583 | ||
| Pubmed | 1.00e-05 | 6 | 29 | 2 | 8940009 | ||
| Pubmed | 1.41e-05 | 7 | 29 | 2 | 10409610 | ||
| Pubmed | 1.41e-05 | 7 | 29 | 2 | 15505202 | ||
| Pubmed | 1.41e-05 | 7 | 29 | 2 | 7819324 | ||
| Pubmed | Regulation of bone morphogenetic protein activity by pro domains and proprotein convertases. | 1.87e-05 | 8 | 29 | 2 | 9885250 | |
| Pubmed | 1.87e-05 | 8 | 29 | 2 | 10037747 | ||
| Pubmed | 1.87e-05 | 8 | 29 | 2 | 7782070 | ||
| Pubmed | 2.41e-05 | 9 | 29 | 2 | 23775089 | ||
| Pubmed | The activation and physiological functions of the proprotein convertases. | 2.41e-05 | 9 | 29 | 2 | 18343183 | |
| Pubmed | The prohormone theory and the proprotein convertases: it is all about serendipity. | 2.41e-05 | 9 | 29 | 2 | 21805236 | |
| Pubmed | 2.41e-05 | 9 | 29 | 2 | 21805237 | ||
| Pubmed | The biology and therapeutic targeting of the proprotein convertases. | 2.41e-05 | 9 | 29 | 2 | 22679642 | |
| Pubmed | 2.41e-05 | 9 | 29 | 2 | 8698813 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 2.71e-05 | 1105 | 29 | 7 | 35748872 | |
| Pubmed | 3.01e-05 | 10 | 29 | 2 | 16163737 | ||
| Pubmed | 3.01e-05 | 10 | 29 | 2 | 26416966 | ||
| Pubmed | 7.02e-05 | 529 | 29 | 5 | 14621295 | ||
| Pubmed | Imaging proprotein convertase activities and their regulation in the implanting mouse blastocyst. | 8.00e-05 | 16 | 29 | 2 | 20876279 | |
| Pubmed | 1.14e-04 | 19 | 29 | 2 | 16950123 | ||
| Pubmed | 1.26e-04 | 20 | 29 | 2 | 23918928 | ||
| Pubmed | Loss of the extraembryonic ectoderm in Elf5 mutants leads to defects in embryonic patterning. | 1.26e-04 | 20 | 29 | 2 | 15829518 | |
| Pubmed | Sall4 isoforms act during proximal-distal and anterior-posterior axis formation in the mouse embryo. | 1.40e-04 | 21 | 29 | 2 | 18781635 | |
| Pubmed | Extraembryonic proteases regulate Nodal signalling during gastrulation. | 1.40e-04 | 21 | 29 | 2 | 12447384 | |
| Pubmed | 1.53e-04 | 22 | 29 | 2 | 21896659 | ||
| Pubmed | Gene network analysis in a pediatric cohort identifies novel lung function genes. | 1.83e-04 | 24 | 29 | 2 | 24023788 | |
| Pubmed | 2.33e-04 | 27 | 29 | 2 | 34709416 | ||
| Pubmed | 2.50e-04 | 28 | 29 | 2 | 16728477 | ||
| Pubmed | 3.49e-04 | 33 | 29 | 2 | 19336002 | ||
| Pubmed | The spatiotemporal expression pattern of Syndecans in murine embryonic teeth. | 3.70e-04 | 34 | 29 | 2 | 32220631 | |
| Pubmed | 3.70e-04 | 34 | 29 | 2 | 20708584 | ||
| Pubmed | Mutation of ARHGAP9 in patients with coronary spastic angina. | 4.63e-04 | 38 | 29 | 2 | 19911011 | |
| Pubmed | 5.75e-04 | 1285 | 29 | 6 | 35914814 | ||
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 6.40e-04 | 203 | 29 | 3 | 22083510 | |
| Pubmed | The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis. | 7.87e-04 | 218 | 29 | 3 | 33378226 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | 8.27e-04 | 1192 | 29 | 5 | chr19q13 | |
| Cytoband | 19q13.41 | 1.12e-03 | 78 | 29 | 2 | 19q13.41 | |
| Cytoband | 19q13.33 | 2.06e-03 | 106 | 29 | 2 | 19q13.33 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q26 | 7.51e-03 | 206 | 29 | 2 | chr15q26 | |
| Cytoband | 19p13.3 | 9.83e-03 | 237 | 29 | 2 | 19p13.3 | |
| GeneFamily | Proprotein convertase subtilisin/kexin family | 4.17e-05 | 9 | 20 | 2 | 973 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.39e-03 | 66 | 20 | 2 | 722 | |
| GeneFamily | Immunoglobulin like domain containing | 1.90e-02 | 193 | 20 | 2 | 594 | |
| Coexpression | KASLER_HDAC7_TARGETS_2_DN | 5.91e-06 | 32 | 29 | 3 | MM913 | |
| Coexpression | KASLER_HDAC7_TARGETS_2_DN | 6.50e-06 | 33 | 29 | 3 | M2322 | |
| Coexpression | GSE3982_MAST_CELL_VS_EFF_MEMORY_CD4_TCELL_DN | 6.10e-05 | 195 | 29 | 4 | M5445 | |
| Coexpression | GSE3982_EFF_MEMORY_CD4_TCELL_VS_NKCELL_DN | 6.47e-05 | 198 | 29 | 4 | M5575 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D122|Adult / Lineage, Cell type, age group and donor | 3.17e-06 | 157 | 29 | 4 | 31d1bd9138c60e8485664ec4144f987226e3eef9 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.25e-06 | 200 | 29 | 4 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.44e-05 | 106 | 29 | 3 | d8868c10785e52a1c22c91e1d0e208f2070393bb | |
| ToppCell | E18.5-samps-Epithelial-Alveolar_epithelial-Uncommitted_AE_Progenitor|E18.5-samps / Age Group, Lineage, Cell class and subclass | 6.92e-05 | 123 | 29 | 3 | 5f002f5180fe47fe57ab888b5f0319df99ab2c59 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.56e-04 | 162 | 29 | 3 | 5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Adult / Lineage, Cell type, age group and donor | 1.59e-04 | 163 | 29 | 3 | e819a1d6d28290854aa0672b3a18fa9e293d8f23 | |
| ToppCell | BAL-Mild-cDC_0|Mild / Compartment, Disease Groups and Clusters | 1.59e-04 | 163 | 29 | 3 | 7047d3ba847930f42a6d5f71e18d49f3071c6409 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.68e-04 | 166 | 29 | 3 | c20479fe7a4306320d7f26e78bf956225f00f35a | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.77e-04 | 169 | 29 | 3 | 96a2aec9acf8a6f966973c035e5ade456cf47772 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 1.80e-04 | 170 | 29 | 3 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.83e-04 | 171 | 29 | 3 | b51bbeacb172e8b5de519ada85543d7ae9914b3c | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-CD8+/CD4+_Mixed_Th|T/NK_cells / Location, Cell class and cell subclass | 1.90e-04 | 173 | 29 | 3 | 42c911ed16fabdabef063830e8407192d8bde950 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Lymphocytic-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-04 | 174 | 29 | 3 | 6987fe7959afce347282f632abc16d800ccab7c4 | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-Double_negative_thymocyte,_DN3_(Cd8-,_Cd4-),_some_express_pre_TCR_alpha|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-04 | 174 | 29 | 3 | a9f34d1237f335d27c5560ff514368f4709f9144 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-plasmablast-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.96e-04 | 175 | 29 | 3 | 89bf89466191da14896ed8928027f5b911436c22 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.00e-04 | 176 | 29 | 3 | 682a1dfcc507ec540f5fadf08e872533ea9f0291 | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-DN3_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-04 | 176 | 29 | 3 | d43d9e86c4d4fa1e88fbf2b899ac7143717aac90 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.00e-04 | 176 | 29 | 3 | 3bbac5c2397535631fce8fa98f6ddb4fe0260351 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.06e-04 | 178 | 29 | 3 | f5ed4a6e3eb8056b1be1fb311021710c95bdf888 | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 2.13e-04 | 180 | 29 | 3 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 2.17e-04 | 181 | 29 | 3 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.24e-04 | 183 | 29 | 3 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 2.27e-04 | 184 | 29 | 3 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 2.31e-04 | 185 | 29 | 3 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | COPD-Epithelial-ATI|COPD / Disease state, Lineage and Cell class | 2.35e-04 | 186 | 29 | 3 | df0977f6f48a2d4e11b59971f098b01204242f0f | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.38e-04 | 187 | 29 | 3 | 4ae7465174e0295d2c3b614b321a3b2f514dd22a | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.38e-04 | 187 | 29 | 3 | 5df9e1f5ca32217af255e76e6fb5afa346337811 | |
| ToppCell | COPD-Epithelial-ATII|COPD / Disease state, Lineage and Cell class | 2.42e-04 | 188 | 29 | 3 | eb6d79d733b53f64ca615bb777c64ed456866549 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 2.42e-04 | 188 | 29 | 3 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.42e-04 | 188 | 29 | 3 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D231|Adult / Lineage, Cell type, age group and donor | 2.46e-04 | 189 | 29 | 3 | dab54a52358f66a8a9460cd6089a06c5fa7e7a5d | |
| ToppCell | COVID-19-lung-AT2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.50e-04 | 190 | 29 | 3 | 27a1a86620fe9b5ee930d388b32352206485e6d0 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.54e-04 | 191 | 29 | 3 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.54e-04 | 191 | 29 | 3 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 2.54e-04 | 191 | 29 | 3 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_immature-endo_immature_arterial2_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.54e-04 | 191 | 29 | 3 | e3fc5c92491b6e334abffbf085c00a0b5fa1aed2 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.58e-04 | 192 | 29 | 3 | cc9911e182a289779a2612bc213daae5607689e7 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 2.58e-04 | 192 | 29 | 3 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 2.58e-04 | 192 | 29 | 3 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 2.58e-04 | 192 | 29 | 3 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 2.58e-04 | 192 | 29 | 3 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 2.62e-04 | 193 | 29 | 3 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 2.62e-04 | 193 | 29 | 3 | 503a979328c68b096680b71359a26f02fafdff35 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.62e-04 | 193 | 29 | 3 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.62e-04 | 193 | 29 | 3 | 64edc1d6fb0fe117767d494cf4a5723bf8be2804 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.62e-04 | 193 | 29 | 3 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.66e-04 | 194 | 29 | 3 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.66e-04 | 194 | 29 | 3 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.70e-04 | 195 | 29 | 3 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.74e-04 | 196 | 29 | 3 | 7e5addaa844e66f8160e05858c341866a80aed23 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.82e-04 | 198 | 29 | 3 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.82e-04 | 198 | 29 | 3 | f948391296c261c473d339069a6d0f20ccd6f38f | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.86e-04 | 199 | 29 | 3 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.86e-04 | 199 | 29 | 3 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.86e-04 | 199 | 29 | 3 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | COVID-19_Severe-PLT_5|World / Disease Group and Platelet Clusters | 2.86e-04 | 199 | 29 | 3 | 937e4028f896bc6b751182517611825d6716c682 | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.86e-04 | 199 | 29 | 3 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.86e-04 | 199 | 29 | 3 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | Transverse-Macrophage-LYVE1_Macrophage|Macrophage / Region, Cell class and subclass | 2.86e-04 | 199 | 29 | 3 | fd75dccb37d96448edf72b7d042b06833d4ead24 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_alveolar-AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.90e-04 | 200 | 29 | 3 | b535323e18d9fb0dde1e0026df142c831e48c29f | |
| ToppCell | Bronchial-10x5prime-Epithelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.90e-04 | 200 | 29 | 3 | d3ee5f79513e2ac02ad3329b59e6290d457c44d2 | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.90e-04 | 200 | 29 | 3 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| Disease | cortical thickness | 6.33e-06 | 1113 | 28 | 8 | EFO_0004840 | |
| Disease | insomnia measurement | 7.71e-04 | 443 | 28 | 4 | EFO_0007876 | |
| Disease | susceptibility to common cold measurement | 1.21e-03 | 54 | 28 | 2 | EFO_0008417 | |
| Disease | mucocutaneous lymph node syndrome | 2.37e-03 | 76 | 28 | 2 | EFO_0004246 | |
| Disease | handedness | 4.55e-03 | 106 | 28 | 2 | EFO_0009902 | |
| Disease | FEV/FEC ratio | 5.47e-03 | 1228 | 28 | 5 | EFO_0004713 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | 6.57e-03 | 801 | 28 | 4 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LYEDAHRAGAPRQAE | 151 | Q9HCE6 | |
| SHPDYRALDDAFAAV | 261 | Q9NXL2 | |
| VRHARAYAEAAAAPA | 16 | P30049 | |
| ANDDPHGVFALYSDR | 4756 | Q8WXG9 | |
| EPRARHAAAAFALDA | 276 | Q8NDT2 | |
| HFERAAPEDSGRYRC | 3351 | P98160 | |
| ANEALARPRPHSDDY | 1326 | Q9Y6X6 | |
| GPAEADRVAAAHGYL | 81 | P29122 | |
| ALHAAARQGPDAYTD | 101 | Q9UBC1 | |
| REDPAASLDAYAHAL | 426 | Q8TCG5 | |
| YPAAAFIDRALSDDH | 126 | Q68J44 | |
| LAARPHDYSADGFND | 516 | P09958 | |
| ECVYAPEAFRGHARD | 236 | Q7Z7A3 | |
| GAAPAAYDAADTHLR | 21 | Q14353 | |
| PLAALYAGHRGDDEA | 811 | Q9UJ99 | |
| YHPDRNSGSAEAAER | 76 | Q96LL9 | |
| ARAAAAAHGDPYREE | 301 | Q9H4Q3 | |
| SAEVDAAGPAASHRY | 311 | P98161 | |
| RAEYADRHAELSGSP | 506 | Q9BTC8 | |
| RRDPFDAARGADFDH | 36 | Q9NXL6 | |
| EPYAGYDRHNAEVAA | 136 | O75063 | |
| YALERAAHASADLPE | 1491 | Q5JSZ5 | |
| DAYRLAAAGDFGHDE | 791 | Q9H254 | |
| PYLHVDSAAQRGAED | 1236 | O95359 | |
| DRYDNHPDPAFGVAR | 586 | Q9C026 | |
| HREAAADVSVFYGPD | 386 | Q86VR7 | |
| ERHFRPVAAAAAAAG | 266 | Q9H4Z2 | |
| DYAHAEARKSPALDG | 266 | Q6PFW1 | |
| AYAAEAARLGPAVAA | 61 | O15399 |